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Neurobiology of Disease

Schwann Cell Mitochondrial Metabolism Supports
Long-Term Axonal Survival and Peripheral Nerve Function
Andreu Viader,1 Judith P. Golden,2 Robert H. Baloh,3,5 Robert E. Schmidt,4,5 Daniel A. Hunter,6 and Jeffrey Milbrandt1,5
1

Department of Genetics, 2Pain Center and Department of Anesthesiology, 3Department of Neurology, 4Department of Pathology, 5Hope Center for
Neurological Disorders, and 6Division of Plastic and Reconstructive Surgery, Washington University School of Medicine, St. Louis, Missouri 63110

Mitochondrial dysfunction is a common cause of peripheral neuropathies. While the role of neuron and axonal mitochondria in peripheral nerve disease is well appreciated, whether Schwann cell (SC) mitochondrial deficits contribute to peripheral neuropathies is unclear.
Here, we examine how SC mitochondrial dysfunction affects axonal survival and contributes to the decline of peripheral nerve function
by generating mice with SC-specific mitochondrial deficits. These mice (Tfam-SCKOs) were produced through the tissue-specific deletion
of the mitochondrial transcription factor A gene (Tfam), which is essential for mitochondrial DNA (mtDNA) transcription and maintenance. Tfam-SCKOs were viable, but as they aged, they developed a progressive peripheral neuropathy characterized by nerve conduction
abnormalities as well as extensive muscle denervation. Morphological examination of Tfam-SCKO nerves revealed early preferential loss
of small unmyelinated fibers followed by prominent demyelination and degeneration of larger-caliber axons. Tfam-SCKOs displayed
sensory and motor deficits consistent with this pathology. Remarkably, the severe mtDNA depletion and respiratory chain abnormalities
in Tfam-SCKO mice did not affect SC proliferation or survival. Mitochondrial function in SCs is therefore essential for maintenance of
axonal survival and normal peripheral nerve function, suggesting that SC mitochondrial dysfunction contributes to human peripheral
neuropathies.

Introduction
Peripheral neuropathies are a heterogeneous group of disorders
characterized by peripheral nerve abnormalities. With an incidence of up to 8% in elderly populations, peripheral neuropathies are a common cause of substantial morbidity and constitute
a significant economic and societal burden (Hughes, 2002). The
etiology for these diseases is varied, ranging from vascular and
metabolic irregularities to genetic mutations. Despite this apparent diversity, mitochondrial derangements have emerged as a
common cause of many types of peripheral neuropathy. A number of mutations that affect mitochondrial function are now
thought to be responsible for several forms of inherited neuropathies (Niemann et al., 2006). Similarly, diabetic neuropathy, the
most prevalent form of peripheral nerve disease, is also associated
with abnormalities in mitochondrial morphology and metabo-
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lism (Fernyhough et al., 2003). With the hope of developing new
therapies, therefore, much effort is being devoted to understanding how mitochondrial deficiencies influence nerve function.
In recent years, significant progress has been made in elucidating the role of axonal mitochondria in peripheral neuropathies (Baloh, 2008). Peripheral nerve axons, however, do not
function in isolation. Schwann cells (SCs), the main glial cell type
in the PNS, are intimately associated with all peripheral nerve
axons and are essential for their long-term preservation and survival (Chen et al., 2003; Reddy et al., 2003; Meyer zu Horste et al.,
2007). Mitochondrial dysfunction in SCs is thus likely to participate in the disease progression in peripheral neuropathies. In
fact, pathological mitochondria in neuropathic nerves are often
localized to SCs (Schroder, 1993; Kalichman et al., 1998). The
contribution of SC mitochondrial dysfunction to the pathology
observed in peripheral nerve diseases, however, is poorly understood and remains largely unexplored.
With the goal of understanding whether SC mitochondrial
abnormalities affect axonal survival and contribute to the decline
of patients suffering from peripheral nerve diseases, we generated
mice with impaired mitochondrial function exclusively in SCs.
These Tfam-SCKO mice were generated through the tissuespecific deletion of the mitochondrial transcription factor A gene
(Tfam), which is required for mitochondrial DNA (mtDNA)
transcription and replication (Larsson et al., 1998). Here, we
show that mitochondrial function in SCs is essential for maintenance of axonal survival and normal peripheral nerve function.
Importantly, SC mitochondrial dysfunction alone recapitulated a
number of critical features of human neuropathies. Remarkably,
the severe mtDNA depletion and respiratory chain abnormalities
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in Tfam-SCKO mice did not affect SC survival. SC mitochondrial
dysfunction, therefore, is a likely contributor to the impairment
of patients suffering from peripheral neuropathies.

Materials and Methods
Matings of transgenic animals. All animal experiments were performed in
compliance with institutional animal protocols. Tfam loxP/loxP mice in a
pure C57BL/6 background (Larsson et al., 1998) were crossed to P0-Cre
mice also in a pure C57BL/6 background (Feltri et al., 1999). Compound
heterozygotes (P0-Cre ⫹/⫺, Tfam ⫹/loxP) were then backcrossed to homozygous
Tfam loxP/loxP to generate the Tfam-SCKO mice (P0-Cre ⫹/⫺, Tfam loxP/loxP) and
their control (ctrl) littermates (P0-Cre ⫺/⫺, Tfam loxP/loxP). Tfam loxP/loxP mice
were also crossed to homozygosity to Rosa26-YFP reporter mice. Tfam loxP/loxP/
Rosa26-YFP ⫹/⫹ were then crossed to P0-Cre mice using an analogous breeding
scheme. Tfam loxP/loxP genotyping was performed as previously described
(Larsson et al., 1998).
Immunohistochemistry and cell quantification. The following primary
and secondary antibodies were used: rabbit anti-GFP (1:1000; Invitrogen), chicken anti-GFP (1:1000; Aves), rabbit anti-␤III tubulin (1:1000;
Covance), rabbit anti-phosphohistone 3 (1:200; Millipore), rabbit antiKv1.1 (1:100; Abcam), rabbit anti-Nav1.6 (1:100; Millipore), mouse
anti-Caspr (1:1000; gift from Dr. Elior Peles, Weizmann Institute of
Science, Rehovot, Israel), anti-rabbit Cy3 (1:500; Jackson ImmunoResearch Laboratories), streptavidin-conjugated Cy3 (1:500; Jackson ImmunoResearch Laboratories), anti-rabbit Alexa 488 (1:500; Jackson
ImmunoResearch Laboratories), and anti-chicken Alexa 488 (1:500;
Jackson ImmunoResearch Laboratories).
For immunohistochemical analysis of sciatic nerves, nerves were dissected, immersion fixed in 4% paraformaldehyde for 2 h, rinsed with
PBS, and cryoprotected in 30% sucrose. Sciatic nerves were then embedded in Tissue-Tek OCT compound (Sakura Finetek) and sectioned at 6
m. For analysis of DRGs, mice were transcardially perfused with 4%
paraformaldehyde. The entire spinal cord was then dissected, postfixed
in PFA overnight, rinsed in PBS, and cryoprotected in 30% sucrose. After
cryoprotection, DRGs were dissected, embedded in Tissue-Tek OCT
compound, and sectioned at 6 m. For analysis of footpads, footpad skin
was removed from the plantar surface of the hindpaw, immersion fixed
in Zamboni’s fixative for 2 h, rinsed with PBS, and cryoprotected in 30%
sucrose. Skin was sectioned at 30 m in a plane perpendicular to the skin
surface. For analysis of teased nerve fibers, mouse sciatic nerves were
dissected and incubated in 4% paraformaldehyde in PBS for 30 min at
room temperature. The nerves were washed three times in PBS for 5 min
and desheathed, and bundles of nerve were dissected with fine needles in
PBS on Fisherbrand Superfrost Plus microscope slides. Slides were air
dried for at least 2 h at room temperature and stored at ⫺20°C until
staining.
All frozen sections were immunostained by postfixing in ice-cold acetone at ⫺20°C for 10 min and blocking in 10% horse serum (DRG and
footpads) or 5% fish skin gelatin (sciatic nerve and teased fibers) in
PBS– 0.2% Triton for 1 h at room temperature. Sections were then incubated with primary antibody diluted in blocking buffer overnight at 4°C.
Secondary antibody incubation was performed at room temperature for
1 h also in blocking buffer. TUNEL staining was performed as previously
described (Grinspan et al., 1996). After all stainings, sections were
mounted with Vectashield Mounting Medium with DAPI (Vector Laboratories) for microscopic visualization. Images were captured using an
upright microscope equipped for epifluorescence microscopy (Nikon
80i; CoolSnapES camera) and were processed using MetaMorph, ImageJ,
and Gimp software using global adjustments in brightness and contrast.
All cell number quantifications were performed by counting the cells
of interest in four randomly selected regions in longitudinal nerve sections from each animal assessed (at least three mice per genotype at each
age) at a 20⫻ magnification. Epidermal innervation density was quantified by tracing the dermal– epidermal border and determining the number of fibers that crossed this borders as previously described (Golden et
al., 2010).
Western blotting. Sciatic nerves were isolated, desheathed in PBS, and
immediately frozen in liquid nitrogen. Lysates were prepared by homog-

J. Neurosci., July 13, 2011 • 31(28):10128 –10140 • 10129

enizing the tissue by sonication in a buffer containing 150 mM sodium
chloride, 50 mM HEPES, 1% NP-40, 1 mM EDTA, 1 mM sodium fluoride,
1 mM sodium orthovanadate, and Complete protease inhibitor mixture
(Roche Applied Science). The lysates were clarified by centrifugation at
14,000 rpm for 10 min and quantified using the MicroBCAProtein Assay
kit (Pierce). For Western blotting, the proteins were separated by SDSPAGE and transferred to a PVDF membrane (Millipore). Membranes
were blocked in 5% milk in 0.5% TBS-Tween and incubated overnight
with the appropriate primary antibody. Following incubation with secondary antibodies conjugated to HRP (GE Healthcare), membranes were
developed with SuperSignal West Dura substrate (Pierce). The primary
antibodies used were rabbit anti-Tfam (1:4000; Dr. Nils-Goran Larsson,
Max Planck Institute for Biology of Ageing, Cologne, Germany), mouse
anti-Porin 31HL (ab2) (1:200; Calbiochem), and mouse anti-tubulin (1:
1000; Sigma-Aldrich). The secondary antibodies used were anti-mouse and
anti-rabbit HRP (1:5000; Jackson ImmunoResearch Laboratories).
RNA and DNA preparation and quantitative real-time PCR. Sciatic
nerves were harvested from Tfam-SCKO mice at different ages and
immediately frozen in liquid nitrogen. For RNA isolation, tissue was
homogenized in Trizol reagent (Invitrogen) and total RNA prepared
according to the manufacturer’s protocol. For DNA isolation, tissue
was digested and DNA isolated using DNeasy Blood and Tissue kit
(QIAGEN) according to the manufacturer’s protocol. DNA and RNA
concentration were quantified using an ND-1000 spectrophotometer
(Nanodrop Technologies).
For RNA, qRT-PCR cDNA was reverse transcribed from total RNA
using MMLV reverse transcriptase (Invitrogen). qRT-PCR was performed using a SYBR Green-based detection system on a 7700 Sequence
Detector instrument (Applied Biosystems) as described previously (Nagarajan et al., 2001). Glyceraldehyde-3-phosphate dehydrogenase expression was used to normalize samples and obtain relative expression
values that were used to calculate fold changes. mtDNA content was also
quantified by qRT-PCR using a SYBR Green-based detection system on a
7700 Sequence Detector instrument (Applied Biosystems) in a similar
way as described previously (Nagarajan et al., 2001). Instead of cDNA,
however, 15 ng of total DNA was used per reaction. Primers that recognized a region unique to the mitochondrial genome were used to determine the mtDNA content relative to a serial dilutions standard curve.
mtDNA content values were normalized to nuclear DNA content as
determined by a set of primers directed to the genomic locus of Smrt1.
DNA and RNA qRT-PCR primer sequences were as follows (5⬘–3⬘):
Tfam: forward (F), CAGGAGGCAAAGGATGATTC; reverse (R),
ATGTCTCCGGATCGTTTCAC; GAPDH: F, TGCCCCCATGTTTGTGATG; R, TGTGGTCATGAGCCCTTCC; mt-ND2: F, CGCCCCATTCCACTTCTGATTACC; R, TTAAGTCCTCCTCATGCCCCTATG;
mt-Cox1: F, GAACCCTCTATCTACTATTCGG; R, CAAGTCAGTTTCCAAAGCCT; SDHB: F, TGTAGAGAAGGCATCTGTGG; R,
CGTAGAAGTTACTCAAATCAGGG; mtDNA: F, AAGTCGTAACAAGGTAAGCA; R, ATATTTGTGTAGGGCTAGGG; Nuc.DNA: F,
GGGTATATTTTTGATACCTTCAATGAGTTA;
R,
TCTGAAACAGTAGGTAGAGACCAAAGC.
Mitochondrial isolation, respiratory enzyme activity measurements, and
respirometry. For mitochondrial isolation, four sciatic nerves were dissected, desheathed, mechanically dissociated, digested with collagenase
for 20 min, and pooled together in 2 ml of homogenization buffer (HM)
containing 0.22 M mannitol, 70 mM sucrose, 10 mM Tris-HCl, 0.5 mM
EDTA, 1 mM EGTA, and 0.5% delipidated BSA. Nerves were homogenized for ⬃2 min (12 strokes) using a Teflon-glass homogenizer turning
at 200 rpm. The homogenate was then centrifuged at 800 ⫻ g for 10 min.
The clarified supernatant was centrifuged at 8000 ⫻ g for 10 min, and the
pellet was resuspended in 1 ml of HM buffer without BSA and spun once
more at 7500 ⫻ g. The resulting pellet was resuspended in 250 l of HM
buffer without BSA. The protein concentration of the resuspended mitochondrial fractions was determined using a MicroBCAProtein Assay
kit (Pierce). Five micrograms of protein from these mitochondrial preps
were used to measure complex II and complex IV activity spectrophotometrically as previously described (Birch-Machin and Turnbull, 2001).
For high-resolution respirometry, two sciatic nerves were dissected,
briefly digested with collagenase for 10 min, and then desheathed and
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fluffed using a pair of fine forceps. At this point, nerve respiration was
measured in a 2 ml chamber using an OROBOROS Oxygraph 2k (Oroboros) as previously described (Mancuso et al., 2010).
Surgical procedure. Mice were anesthetized by intraperitoneal injection
of 2-2-2 tribromoethanol at a dose of 500 mg/kg. The sciatic nerve was
exposed at the hip and a reproducible crush injury was created by using
no. 5 jeweler’s forceps for 30 s. The site of injury was marked with a single
10-0 nylon epineural suture. Nerve lesions were produced on the right
side and the contralateral nerve was left intact and served as the uninjured
control. At the appropriate time, nerves were harvested and processed for
histology.
Nerve light and electron microscopy and morphometry. Sciatic nerves
from ctrl and Tfam-SCKO mice at different ages were dissected and
placed in 3% glutaraldehyde overnight. After washing with phosphate
buffer, nerves were postfixed in 1% osmium tetroxide in phosphate buffer overnight at 4°C. Specimens were then dehydrated in graded alcohols
and embedded in 100% epoxy (Araldite 502). One-micrometer-thick
plastic-embedded sections were prepared and stained with toluidine blue
for light microscopy. For electron microscopy, thin sections were prepared, stained with uranyl acetate and lead citrate, and photographed
with a JEOL 1200 electron microscope. All nerves underwent qualitative
assessment of neural architecture followed by detailed histomorphometric analysis performed as previously described (Hunter et al., 2007).
Nerve electrophysiology and electromyography. Electrophysiology and
electromyography were performed on mice at 2, 4, and 8 months of age
using a Viking Quest electromyography machine (Nicolet) as previously
described (Baloh et al., 2009). Briefly, mice were anesthetized with Avertin and placed on a heating pad. For nerve electrophysiology, subcutaneous platinum subdermal EEG electrodes (0.4 mm diameter, 12 mm
length) (Viasys) were used. Stimulating electrodes were placed just above
the left ankle and the left sciatic notch for nerve stimulation. Recording
electrodes were placed in the footpad. Evoked compound motor action
potentials were obtained using supramaximal stimulation, and distance
between the two sites of stimulating electrodes was used to calculate
conduction velocity. For electromyography (EMG) recordings, a 27gauge, Teflon-coated, monopolar needle electrode with a 70 ⫻ 500 m
recording surface (PRO-37SAF; Electrode Store) was used. A 29 gauge
reference needle electrode (GRD-SAF; Electrode Store) was inserted subcutaneously in close approximation to the recording electrode. A subdermal ground electrode was placed on the back. The recording electrode
was inserted into the tibialis anterior or gastrocnemius/soleus muscles,
and spontaneous electrical activity was recorded for 90 s.
Muscle histology. Gastrocnemius muscles were dissected fresh and immediately frozen in isopentane cooled in liquid nitrogen. Cryostat sections of gastrocnemius muscle were cut at 10 m onto slides and stained
with hematoxylin and eosin.
Nerve cytochrome oxidase staining. Sciatic nerves were dissected fresh,
placed in Tissue-Tek OCT compound, and immediately frozen in isopentane cooled in liquid nitrogen. Tissue was then sectioned at 6 m.
Sections were placed in an incubating solution containing sucrose (100
mg/ml), DAB (3,3⬘-diaminobenzidine tetrahydrochloride 2) (0.6 mg/
ml), sodium phosphate buffer (final concentration, 0.05 M), catalase 3
(2.6 g/ml), and cytochrome c (1.6 mg/ml) for 60 min at room temperature. After incubation, sections were washed three times with deionized
water, dehydrated in a series of ascending alcohols and cleared with
xylene, and mounted using Permount.
Behavioral testing. Behavioral testing was performed using male and
female Tfam-SCKO mice and littermate controls at 2 and 4 months of
age. The experimenter was blind to the genotypes of the mice during data
acquisition. Noxious heat sensitivity (Hargreaves test) was determined as
previously described (Golden et al., 2010). Briefly, the thermal threshold
was determined by measuring the withdrawal latency to a radiant heat
source applied to the plantar surface of the hindpaw in five separate trials
for each hindpaw with a 15 min interval between trials. The withdrawal
threshold was determined by averaging the withdrawal latency obtained
in each of the trials. Mechanical sensitivity was determined using the von
Frey test. Beginning with the smallest filament and continuing from
smallest to largest, calibrated von Frey filaments were pressed to the
plantar surface of the hindpaw until the filament just bent. The with-

drawal threshold is defined as the force that produces a withdrawal response in three of five consecutive applications within one trial. The
threshold was determined in three trials per hindpaw with a 15 min
interval between trials. An accelerating rotarod was used to evaluate motor coordination and balance. Five consecutive acceleration trials were
performed with a 5 min interval between trials as described previously
(Montana et al., 2009). Muscle strength was measured using an inverted
screen test as previously described (Golden et al., 2010).
Osmicated teased sciatic nerve fibers. Sciatic nerves were dissected and
immersion fixed in 3% glutaraldehyde overnight. After washing with 0.1
M phosphate buffer, nerves were incubated in 1% osmium tetroxide plus
1.5% potassium ferricyanide in 0.5 M phosphate buffer for 1 h. Nerves
were washed in PBS followed by incubation in 33, 66, and 100% glycerol/
PBS for 6 h each. Nerves were then treated with 0.6% Sudan Black dissolved in 70% ethanol at 25°C for 30 min, rinsed with 70% ethanol and
with water, and then placed back in 100% glycerol. Nerves were teased in
100% glycerol and coverslipped for imaging.
Statistical analysis. All values are expressed as mean ⫾ SEM. If not
stated otherwise, p values were determined by unpaired, two-tailed Student’s t test. In all applicable figures, an asterisk (*) indicates statistical
significance and p values are indicated in the legends. All statistical analyses were performed using Microsoft Excel 2007.

Results
Schwann cell-specific disruption of the Tfam gene
To study how mitochondrial dysfunction affects SCs and their
ability to support long-term axonal survival, we generated mice
with disrupted mitochondria only in SCs (Tfam-SCKOs). For
this purpose, we used a previously developed mouse with loxPflanked Tfam alleles (Tfam loxP) (Larsson et al., 1998) (Fig. 1a).
TFAM is a nuclearly encoded mitochondrial protein that is essential for mtDNA maintenance, copy number regulation, and
transcription (Larsson et al., 1998; Ekstrand et al., 2004). Previous reports have shown that the deletion of Tfam in TfamloxP
homozygous mice that express cre-recombinase in a tissue of
interest results in severe tissue-specific mtDNA depletion and
mitochondrial respiratory chain deficiency (Larsson et al., 1998;
Wang et al., 1999; Silva et al., 2000; Sorensen et al., 2001; Wredenberg et al., 2002). This makes the tissue-specific deletion of
Tfam an effective way to induce mitochondrial dysfunction in a
selected population of cells.
We mated Tfam loxP mice to mice that express crerecombinase under the control of the P0 promoter (P0-Cre) (Feltri et al., 1999). P0-Cre mice are well established to induce specific
recombination of floxed genes in peripheral myelinating and
nonmyelinating SCs starting at E13.5–E14.5, but not in any other
central or peripheral neuron or glia (Feltri et al., 1999, 2002). We
confirmed this selectivity by crossing P0-Cre mice with Creinducible Rosa26-YFP reporter animals. Indeed, yellow fluorescent
protein (YFP) fluorescence was visible in most sciatic nerve SCs but
not in axons or perineurial cells. Similarly, YFP could also be seen in
most dorsal root ganglia SCs (satellite cells) but not in DRG neurons
(Fig. 1b). In agreement with previous reports, therefore, P0-Cre induced selective recombination in most peripheral SCs.
The observed P0-Cre-mediated excision of Tfam in SCs was
highly efficient. Analysis of Tfam mRNA and protein levels from
Tfam-SCKO sciatic nerve extracts showed an 80% reduction
compared with littermate controls (Fig. 1c,d). Considering that
an estimated 15% of endoneurial cells are P0-Cre negative fibroblast and macrophages (King, 2005) and that nerve extracts also
contain some perineurial and endothelial cells, the actual excision
rate of Tfam in SCs was probably near complete. Given the high
selectivity and efficiency of the P0-promoter driven expression of
cre-recombinase, we conclude that the mating of Tfam loxP to P0-Cre
mice resulted in animals that lacked Tfam specifically in SCs.
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control animals (Fig. 2a). Similarly, transcripts of two different mitochondrially encoded proteins (mt-ND2 and mt-Cox1)
were also severely depleted in the sciatic
nerves of Tfam-SCKO animals (Fig. 2b). As
expected, no differences in the transcript
levels of nuclearly encoded mitochondrial
proteins were observed (Fig. 2b).
The mitochondrial genome encodes
13 subunits that are essential components
of complexes I, III, IV, and V of the electron transport chain. The depletion of
mtDNA and mitochondrially encoded
transcripts following Tfam excision has
been previously shown to induce severe
respiratory chain deficiency (Larsson et
al., 1998; Wang et al., 1999; Silva et al.,
2000; Sorensen et al., 2001; Wredenberg et
al., 2002). To examine the dysfunction of
SC mitochondria in Tfam-SCKO mice,
we first assessed respiratory chain enzyme
activities in the sciatic nerves of 2-monthold animals. At this age, Tfam has already
been efficiently excised in sciatic nerve
SCs and mtDNA content and transcripts
have been severely depleted (Figs. 1c,d,
2a,b). Mitochondria isolated from TfamSCKO sciatic nerves showed a 60% reduction in cytochrome oxidase (COX) activity
(complex IV), which contains critical
mtDNA-encoded subunits (Fig. 2c). As expected, the activity of succinate dehydrogenase (SDH) (complex II), which is fully
nuclearly encoded, showed no significant
change in mitochondria isolated from
Tfam-SCKO sciatic nerves (data not
shown).
To further confirm the disruption of
SC mitochondria in Tfam-SCKO mice,
Figure 1. P0-Cre deletes Tfam from SCs specifically and efficiently in Tfam-SCKO mice. a, Diagram of the targeted Tfam locus in we next used high-resolution respiromeTfam loxP mice. When Tfam loxP mice are crossed with mice that express Cre recombinase under the control of the P0 promoter, exons try to measure mitochondrial respiration
6 and 7 of Tfam are excised to produce Tfam ⫺ mice. b, YFP fluorescence in SCs (arrowheads) of longitudinal sciatic nerve sections under different substrates in permeabil(ScN), as well as satellite SCs (arrowheads) in DRGs of Rosa26-YFP/P0-Cre mice. P0-Cre induces recombination specifically in SCs and ized 2-month-old Tfam-SCKO sciatic
excision-dependent YFP fluorescence is localized to regions of SC cytoplasm but not to axons (Tuj1 and stars; note non-overlapping nerves. Respiration induced by substrates
Tuj1 and YFP staining) or DRG neuron cell bodies (stars). Scale bars: Top and bottom panels, 100 m; middle magnified panel, 50 delivering electrons to complex I (pyrum. c, qRT-PCR results showing efficient depletion of Tfam mRNA in Tfam-SCKO sciatic nerves. Tfam mRNA levels in the sciatic vate plus malate) was significantly imnerve of 1-month-old Tfam-SCKOs were decreased by 60% (p ⫽ 0.001, two-tailed Student’s t test) compared with ctrl littermates. paired in Tfam-SCKO sciatic nerves
By 2 months of age Tfam mRNA levels were reduced by 85% (p ⫽ 0.002, two-tailed Student’s t test) compared with ctrl littermates. compared with littermate controls. SimiReported values are normalized to GAPDH. Error bars indicate SEM. n ⫽ 2 pools of 3 mice run in 3 independent experiments. d, larly, respiration induced by the converWestern blot showing efficient depletion of Tfam protein in the sciatic nerves of Tfam-SCKO mice compared with ctrl littermates by
gent transport of electrons entering at
2 months of age.
complexes I and II (using pyruvate plus
malate plus succinate as substrates),
SC mtDNA depletion and respiratory dysfunction
which best corresponds to the mitochondrial substrate supply in
in Tfam-SCKOs
vivo (Gnaiger, 2009), was also significantly reduced in TfamTo determine the functional effect of deleting Tfam in SCs, we
SCKO sciatic nerves compared with littermate controls. These
next assessed mtDNA copy number and transcript level in Tfamreductions in mitochondrial respiration in Tfam-SCKO nerves
SCKO sciatic nerves. Consistent with the essential role of Tfam in
are likely explained by defects in complexes I, III, and IV as these
the maintenance, replication, and transcription of mtDNA
complexes contain mtDNA-encoded subunits. Respiration induced
(Larsson et al., 1998; Ekstrand et al., 2004), as well as with preby electrons entering at the level of complex II remained unchanged
vious reports describing tissue-specific Tfam knock-out mice
in Tfam-SCKO nerves, which is explained by the fact that complex II
(Larsson et al., 1998; Wang et al., 1999; Silva et al., 2000; Sorensen et
contains only nuclearly encoded subunits (Fig. 2d).
al., 2001; Wredenberg et al., 2002), total mtDNA content was found
It should be emphasized that, while the functional deficits
to be significantly reduced in Tfam-SCKO nerves compared with
described above were measured from whole Tfam-SCKO sciatic

10132 • J. Neurosci., July 13, 2011 • 31(28):10128 –10140

Viader et al. • Schwann Cell Mitochondria Support Axonal Survival

nerves, they are a reflection of the mtDNA
depletion and mitochondrial dysfunction
taking place specifically in SCs. The high
specificity of the P0-cre-mediated excision
of Tfam ensures this (Fig. 1b). Moreover,
COX enzymatic staining, which reflects
respiratory chain activity in individual
cells, showed reduced staining intensity in
the cell bodies of SCs in Tfam-SCKO sciatic nerves (Fig. 2e). Finally, electron microscopy of Tfam-SCKO nerves revealed
abundant abnormal, enlarged mitochondria, sometimes with distorted cristae,
specifically in SC but not in axons (Fig.
2f ). Together, our results confirm that, by
deleting Tfam specifically in SCs, we were
able to generate a mouse with disrupted
mitochondrial metabolism only in peripheral glia.
Tfam-SCKOs develop a progressive
degenerative peripheral neuropathy
Despite severe mtDNA and transcript
depletion as well as respiratory chain
dysfunction in their SCs, Tfam-SCKO animals were born at the expected Mendelian ratios and survived to at least 12
months of age (the longest a Tfam-SCKO
was allowed to survive before it was
killed). Tfam-SCKO animals developed
normally and were indistinguishable from
their control littermates up to 3 months
of age. Starting at 3– 4 months of age,
however, Tfam-SCKOs showed signs of
muscle weakness and gait abnormality.
Tfam-SCKOs exhibited abnormal limb Figure 2. SC-specific excision of Tfam induces mtDNA and transcript depletion and respiratory dysfunction in Tfam-SCKOs. a, qRT-PCR
clasping, mild tremors, and impaired co- results showing depletion of mtDNA content in the sciatic nerves of Tfam-SCKO mice compared with littermate ctrls. mtDNA content was
ordination, and developed a characteristic significantly reduced by 50% (p ⫽ 0.01, two-tailed Student’s t test) in 2-month-old Tfam-SCKO sciatic nerves compared with ctrl nerves.
“swimming gait.” These deficits progres- Reported values are normalized to nuclear DNA content. Error bars indicate SEM. n ⫽ 3 mice per genotype run in 2 independent experisively worsened so that, by 8 months of ments. b, qRT-PCR results showing depletion of mitochondrially encoded electron transport chain subunit transcripts (mt-ND2 and
age, most Tfam-SCKOs were often unable mt-Cox1) in Tfam-SCKO sciatic nerves. mRNA levels of these subunits were decreased 85% (p ⫽ 0.02, two-tailed Student’s t test) in
to support themselves on their hind legs 2-month-oldTfam-SCKOsciaticnervescomparedwithctrllittermates.Incontrast,transcriptsofnuclearlyencodedelectrontransportchain
(Fig. 3a). Such motor abnormalities are subunits (nuclear SDHB) are not depleted in Tfam-SCKO sciatic nerves. Reported values are normalized to GAPDH. Error bars indicate SEM.
indicative of peripheral nerve disease and n ⫽ 2 pools of 3 mice run in 3 independent experiments. c, Respiratory chain enzyme activity measured from mitochondria isolated from
thesciaticnervesof2-month-oldTfam-SCKOnervesandctrllittermates.COXactivity(complexIV),whichcontainscriticalmtDNA-encoded
have been previously described in other subunits, is reduced 65% (p ⬍ 0.01, two-tailed Student’s t test) in Tfam-SCKO mice. Error bars indicate SEM. n ⫽ 3 pools of 2 mice per
mouse models of peripheral neuropathy genotype. d, Mitochondrial respiration in 2-month-old Tfam-SCKO and littermate ctrl permeabilized sciatic nerves measured using high(Le et al., 2005; Ryu et al., 2007; Baloh et resolutionrespirometry.RespirationinducedbysubstratesdeliveringelectronstocomplexI(pyruvateplusmalate)isreducedby35%(p⫽
al., 2009).
0.04, two-tailed Student’s t test) in Tfam-SCKO sciatic nerves compared with littermate controls. Respiration induced by the convergent
Reduced peripheral nerve conduction transport of electrons entering at complexes I and II (using pyruvate plus malate plus succinate as substrates) is decreased by 25% (p ⫽
velocity is a hallmark and diagnostic 0.04, two-tailed Student’s t test) in Tfam-SCKO sciatic nerves compared with littermate ctrls. Respiration induced by substrates delivering
marker of diabetic as well as other electrons to complex II alone (succinate), which is fully nuclearly encoded, was not significantly changed in Tfam-SCKO nerves compared
mitochondria-related neuropathies (Ar- withlittermatectrls.ErrorbarsindicateSEM.n⫽5micepergenotype.e,COXenzymaticstainingof4-month-oldctrlandTfam-SCKOsciatic
ezzo and Zotova, 2002). To further char- nerves. The intense COX staining that localizes to SCs in ctrl nerves (arrowheads) is largely lost in Tfam-SCKO nerves, indicating mitochonacterize the peripheral nerve deficits in drial dysfunction specifically in this cell type. f, Electron micrographs of Tfam-SCKO sciatic nerves show abundant abnormal enlarged
mitochondria(arrowheads),oftenwithdistortedcristae.AberrantmitochondriaaremainlyfoundinSCs,whileaxonalmitochondriashow
Tfam-SCKOs, we performed nerve con- nomorphologicalabnormalities(arrows).Pathologicalmitochondriaarevisibleasearlyas1monthinTfam-SCKOnerves(top3panels)and
duction studies both on presymptomatic become more abundant as these mice age (bottom panels from 4-month-old mice). Scale bars, 500 nm.
and symptomatic mice. Nerve conduction velocity was significantly reduced in
Interestingly, EMG of Tfam-SCKOs showed occasional fibrilTfam-SCKO animals as early as 2 months of age and this deficit
lation potentials and fasciculations at 2–3 months of age, which
persisted over time (Fig. 3c). Moreover, Tfam-SCKO mice disbecame prominent at 4 months and continued to worsen with
played marked temporal dispersion at 4 months of age (Fig. 3b,d).
increasing age (Fig. 3e) (data not shown). These EMG findings
Both these findings are suggestive of a progressive demyelinating
phenotype in Tfam-SCKO mice.
reflect loss of muscle fiber innervation and spontaneous firing of
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Figure 3. Tfam-SCKOsdevelopaprogressivedegenerativeperipheralneuropathy.a,Photograph
of end-stage Tfam-SCKO mouse (⬇8 months of age). At this stage, Tfam-SCKOs display a characteristicswimminggaitandareunabletosupportthemselvesontheirhindlegs.b,Typicalnerveconductiontracefroma4-month-oldTfam-SCKOmouseshowingmarkedtemporaldispersion.Calibration:1
ms,1mV.c,d,ElectrophysiologicalstudiesofTfam-SCKOmiceshowthat,asearlyas2monthsofage,
these mice have significantly reduced nerve conduction velocity (c) (p ⬍ 0.001, two-tailed Student’s
t test) compared with littermate ctrls. This deficit persists in 4-month-old animals (c) (p ⬍ 0.001,
two-tailed Student’s t test), which also have severe temporal dispersion as shown by an increased
response duration (d) (p ⬍ 0.001, two-tailed Student’s t test). These findings indicate segmental
demyelination.ErrorbarsindicateSEM.N⫽4micepergenotypeateachage.e,Typicalelectromyography traces from a 4-month-old Tfam-SCKO mouse showing fibrillation (arrowheads) and fasciculations (arrows), common findings in diseases involving motor axon loss, indicative of muscle fiber
denervation and motor unit degeneration/regeneration. These findings were never present in ctrl
littermates. Calibration: 50 ms, 500 V. f, Hematoxylin and eosin stain of the gastrocnemius muscle
from a ctrl and a Tfam-SCKO mouse showing scattered and grouped muscle fiber atrophy (arrowheads). This is characteristic of motor axon degeneration. Scale bar, 50 m.

motor units, and are often seen in human nerve diseases involving motor axon loss. Thus, our EMG results indicated a progressive axonal degeneration phenotype in Tfam-SCKO mice. This
was confirmed by muscle histology, which revealed abundant
denervated atrophic muscle fibers (Fig. 3f ). SC-specific mitochondrial dysfunction caused, therefore, a progressive peripheral
neuropathy characterized by both demyelination as well as axonal degeneration.
Tfam-SCKOs display early preferential loss of small
unmyelinated fibers
To examine in detail the peripheral nerve abnormalities in TfamSCKOs, we performed histological and electron microscopy analysis of Tfam-SCKO sciatic nerves at different ages. Tfam-SCKO
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nerves initially developed normally, and for the first 2–3 weeks of
life there were no obvious differences between ctrl and Tfamdeficient nerves (see Notes). As early as 1 month of age, however,
Tfam-SCKO nerves started to display signs of pathology. Interestingly, we found that these early abnormalities preferentially
affected, and were initially limited to, small-caliber unmyelinated
fibers (C-fibers) (Fig. 4a– e).
Small-caliber fibers are normally associated with nonmyelinating SCs, such that a single SC wraps around multiple axons to
form a Remak bundle. The Remak bundle is delimited by a basement membrane and individual axons are kept separate from one
another inside it by a thin extension of SC cytoplasm (Fig. 4e1). At
1 month, the structure of Remak bundles in Tfam-SCKO nerves
was clearly disrupted (Fig. 4d,e). Unmyelinated axons within a
Remak bundle were often found touching one another and interspersed by pathological SC processes known as bands of Bungner
(Fig. 4e2). Moreover, degeneration of unmyelinated axons was
extensive and evidenced by free-floating, excess basement membrane surrounding empty spaces previously occupied by axon
bundles (Fig. 4e2,e3). Precise quantification of small fiber loss in
the nerves of Tfam-SCKO mice, however, was not possible because of the difficulty of distinguishing abnormal unmyelinated
axons from SC processes forming bands of Bungner. Note that, at
this age (1 month old), large-caliber myelinated fibers (A fibers)
in Tfam-SCKO nerves appeared normal (Fig. 4a– c).
The unmyelinated fibers in Tfam-SCKO nerves quickly deteriorated, and by 2 months of age, most nonmyelinating SCs were
associated with unstructured, degenerating Remak bundles.
These bundles contained few intact axons and were often filled
with phagocytic vesicles and membranous debris, indicative of
axonal degeneration (Fig. 4e4 ). We confirmed the early degeneration of unmyelinated fibers observed in Tfam-SCKO sciatic
nerves by quantifying C-fiber density in the epidermis. Somatic
C-fibers are primarily high-threshold nociceptors that terminate
in the epidermis (Kennedy and Wendelschafer-Crabb, 1993). In
neuropathies characterized by loss of small unmyelinated fibers,
skin denervation is one of the initial signs of pathology and correlates with disease severity (Ebenezer et al., 2007). While we did
not observe differences in epidermal fiber density at 1 month of
age, we found a significant decrease in skin innervation in
2-month-old Tfam-SCKO mice (Fig. 4f,g). This was again in contrast to large myelinated fibers, which at this age were just beginning to show initial signs of pathology (Fig. 5a). Overall numbers
of dorsal root ganglion neurons in L3, whose axons project to the
sciatic nerve, were comparable in 2-month-old Tfam-SCKO and
ctrl mice (average total number of neurons: ctrl, 7048 ⫾ 186;
Tfam-SCKO, 7381 ⫾ 211.3; n ⫽ 3 mice per genotype). Similarly,
TUNEL and cleaved caspase 3 immunostaining of the dorsal root
ganglion neurons whose axons project to the sciatic nerve (levels
L3–L5) showed no signs of cell death in either 2- or 4-month-old
Tfam-SCKOs (data not shown). The degeneration of small unmyelinated fibers in the nerves of Tfam-SCKO mice was, therefore, a primary pathological event and was not secondary to
neuronal death.
Together, our results show that Tfam-SCKO mice initially
suffered early preferential loss of small unmyelinated fibers, suggesting that these fibers are most sensitive to SC mitochondrial
dysfunction. The temporal progression of fiber loss in TfamSCKO nerves is particularly interesting because early preferential
loss of small unmyelinated fibers has been reported in polyneuropathies associated with diabetes and HIV/AIDS (Kennedy et
al., 1996; McArthur et al., 2005), diseases in which mitochondrial
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dysfunction is known to occur (Dalakas et al., 2001; Fernyhough
et al., 2003).
Loss of large-caliber myelinated fibers in older Tfam-SCKOs
While Tfam-SCKOs suffered an early preferential loss of small
unmyelinated fibers, these mice also developed deficits in largecaliber myelinated axons as they aged. Toluidine blue-stained
plastic sections of 2-month-old Tfam-SCKO sciatic nerves
showed early signs of axonal degeneration (Fig. 5a). This observation was confirmed by electron microscopic examination,
which revealed a few axons undergoing active demyelination and
Wallerian degeneration (data not shown). Note, however, that at
this age there was not a significant decrease in the number of
myelinating profiles in Tfam-SCKO nerves (Fig. 5b).
Severe axonal loss became prominent in Tfam-SCKOs by 4
months (Fig. 5a– c). At this age, the number of myelinating profiles in Tfam-SCKO nerves was greatly reduced compared with
control littermates (Fig. 5b). Degeneration of myelinated axons
continued to progress as Tfam-SCKO mice aged, and by 8
months of age the number of myelinating profiles in these animals was ⬍40% that of control littermates (Fig. 5a– c3). Electron
micrographs confirmed the severity of the axonal degeneration in
Tfam-SCKO nerves, revealing large portions of endoneurium
completely devoid of axons (Fig. 5c). Similarly, numerous axons
undergoing degeneration were also visible. Detailed morphometric analysis (Hunter et al., 2007) showed no differences in the size
distribution of myelinated axons in Tfam-SCKO nerves compared with control littermates at different ages, indicating that
myelinated fibers of all calibers were susceptible to degeneration
(Fig. 5d). As in the case of small unmyelinated fibers, the degeneration of myelinated fibers was not secondary to neuronal death
since no TUNEL- or cleaved caspase 3-positive motor neurons
were observed in the spinal cords of either 2- or 4-month-old
Tfam-SCKOs (data not shown).
At 4 months, demyelination was also widespread in TfamSCKO nerves. At this age, large-caliber axons without any myelin
were a prominent pathological feature (Fig. 5c). Examination of
osmicated teased fibers from 4-month-old Tfam-SCKO nerves
confirmed the presence of segmental demyelination (Fig. 5e).
Consistent with demyelination, SCs actively digesting myelin debris were present in Tfam-SCKO nerves at this age (Fig. 5c4 ).
Occasionally, axons surrounded by abnormally thin myelin were
also observed. Thin myelin was, however, not characteristic, and
in fact there was no difference in the overall g-ratio between
Tfam-SCKO and control nerves at different ages (data not
shown). Overall, these results show that extensive axonal degeneration and demyelination ensue when SC mitochondria are disrupted. Normal SC mitochondrial function is therefore essential
for maintaining the interaction between myelinating SCs and
axons.
4

Figure 4. Tfam-SCKOs display early preferential loss of small unmyelinated fibers: a– c,
Toluidine blue-stained plastic sections of 1-month-old Tfam-SCKO sciatic nerve and littermate
ctrls (a) show that at this age there are no differences in the number of myelinated fibers (b) or
the extent of myelination ( g-ratio, axon area/fiber area) (c). Scale bar, 25 m. Error bars
indicate SEM. n ⫽ 4 mice per genotype. d, Electron micrographs of 1-month-old ctrl and
Tfam-SCKO sciatic nerves show that, while large myelinated fibers are mostly normal in TfamSCKO mice at this age (arrows), the structure of Remak bundles (arrowheads) is largely abnormal. Scale bar, 2 m. e1– e4, Compared with ctrl littermates (e1), unmyelinated axons in
Tfam-SCKO Remak bundles are found touching one another (e2, e4, stars) and interspersed by

pathological SC processes known as bands of Bungner (e2, arrowheads). Free-floating excess
basement membrane (e2, e3, arrows) enclosing SC cytoplasm (e3, star) with few or no axons
left, indicative of extensive degeneration of unmyelinated axons, is also visible. By 2 months of
age, most nonmyelinating SCs are associated with unstructured, degenerating Remak bundles,
containing abnormal axons (e4, star) and filled with phagocytic vesicles and membranous
debris (e4, arrowhead). Scale bar, 500 nm. f, Representative photographs of epidermal fiber
innervation (arrowheads) in the footpads of 2-month-old Tfam-SCKO and littermate ctrl mice.
Scale bar, 10 m. g, Quantification of fiber density in the epidermis shows a 30% decrease in
Tfam-SCKO by 2 months of age (p ⫽ 0.02, two-tailed Student’s t test), indicating early degeneration of small unmyelinated C-fibers. Results reported are normalized to per unit area. Error
bars indicate SEM. n ⫽ 3 mice per genotype at each age.
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Figure 5. Degeneration of large-caliber myelinated fibers in older Tfam-SCKOs. a, b, Toluidine blue-stained plastic sections of Tfam-SCKO sciatic nerves and littermate ctrls at different ages (a)
and quantification of total number of myelinated profiles per nerve (b). At 2 months, some initial signs of axonal degeneration are apparent (arrowhead) in Tfam-SCKO nerves, but at this age there
are no differences in the number of myelinated fibers (b). By 4 months, there is prominent axonal degeneration, as shown by a significant decrease (p ⬎ 0.001, two-tailed Student’s t test) in the total
number of myelinated profiles in Tfam-SCKO nerves. Axonal degeneration worsens by 8 months of age (p ⬎ 0.001, two-tailed Student’s t test). Scale bar, 25 m. Error bars indicate SEM. n ⫽ 4 mice
per genotype at each age. c1– c4, Electron micrographs of Tfam-SCKO nerves at different ages confirm that large myelinated fiber degeneration becomes prominent by 4 months of age (c2) and
worsens by 8 months (c3), as shown by large portions of endoneurium completely devoid of axons (stars). By 4 months of age, actively demyelinating and degenerating axons filled with
membranous debris (arrowheads) are also common in Tfam-SCKO nerves (c4). By this age, segmental demyelination as shown by large-caliber axons without myelin is also prominent (c2– c4,
arrows). This type of pathology is not visible in ctrl nerves (c1). Scale bar, 2 m. d, Fiber size distribution analysis in Tfam-SCKO and ctrl littermate nerves at different ages. No differences in fiber size
distribution are evident despite severe axonal degeneration, indicating that myelinated fibers of all calibers are susceptible to degeneration. Error bars indicate SEM. n ⫽ 4 mice per group at each
age. e, Osmicated teased fibers from 4-month-old Tfam-SCKO nerves confirm the presence of segmental demyelination. Scale bar, 25 m.

Tfam-SCKOs have behavioral deficits consistent with early
loss of unmyelinated fibers followed by extensive
degeneration of myelinated axons
To determine the physiological effects and confirm the temporal
progression of the pathology observed in Tfam-SCKO nerves, we

performed a battery of sensorimotor tests in 2- and 4-month-old
animals. Behavioral tests that primarily assess the function of
small unmyelinated C-fibers were expected to show deficits in
both 2- and 4-month-old Tfam-SCKO mice. However, behavioral paradigms looking mainly at the function of large myelin-
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large-caliber axons are not affected in Tfam-SCKO mice until
later in the disease. Together, our results confirm that TfamSCKO mice initially suffered early preferential loss of small
unmyelinated fibers followed by extensive loss of large-caliber
myelinated axons.

Figure 6. Tfam-SCKOs have behavioral deficits consistent with early loss of unmyelinated
fibers followed by extensive degeneration of myelinated axons. a, Two-month-old Tfam-SCKOs
are less sensitive to an applied noxious heat stimulus than ctrl littermates (p ⬍ 0.01, two-tailed
Student’s t test), as shown by an increased withdrawal latency, which indicates loss of unmyelinated C-fiber nociceptors. This deficiency persists in 4-month-old Tfam-SCKO mice (p ⬍ 0.01,
two-tailed Student’s t test). b– d, At 2 months of age, consistent with the early preservation of
large myelinated motor axons, Tfam-SCKOs do not display significant motor deficits as shown
by the inverted screen test (b) or accelerating rotarod (c). Four-month-old Tfam-SCKOs, however, spend significantly less time on an inverted screen (p ⬍ 0.01, two-tailed Student’s t test)
(b) and accelerating rotarod (p ⬍ 0.01, two-tailed Student’s t test) (d), motor deficits that
indicate the loss of large myelinated fibers by this age. Error bars indicate SEM. N ⫽ 4 mice per
genotype at each age.

ated fibers were predicted to show differences only in 4-monthold Tfam-SCKO mice.
Small unmyelinated C-fibers have a primary role in nociception. To examine the physiological effect of the early C-fiber loss
observed in Tfam-SCKOs, we assessed their sensitivity to a noxious heat stimulus. When a noxious radiant heat stimulus was
applied to the hindpaw (Hargreaves test), Tfam-SCKOs displayed a longer withdrawal latency than their control littermates.
As expected, this reduced sensitivity to noxious heat stimuli was
detectable in 2-month-old animals and persisted as these mice
aged (Fig. 6a).
We also tested innocuous mechanical sensitivity in 2-monthold Tfam-SCKOs using the von Frey test. Innocuous mechanical
sensitivity is another form of somatosensation, but, unlike nociception, it is primarily mediated by myelinated fibers. Interestingly, 2-month-old Tfam-SCKO animals showed no deficits in
the von Frey test compared with wild-type littermate controls
(average withdrawal threshold: ctrl, 0.86 ⫾ 0.08 g; Tfam-SCKO,
1.0 ⫾ 0.05 g; n ⫽ 4 mice per genotype). The results from these
somatosensory studies supported the pathological observations
indicating early preferential loss of small unmyelinated fibers in
Tfam-SCKO mice.
Given that the axons of motor neurons are large myelinated
fibers, we next determined whether the pathology observed in
Tfam-SCKO nerves caused any abnormalities in motor function.
As predicted, no motor deficits were detected in 2-month-old
Tfam-SCKOs (Fig. 6b,c). Four-month-old Tfam-SCKO animals,
however, spent significantly less time on an accelerating rotarod
(Fig. 6d) as well as on an inverted screen (Fig. 6b), indicating
abnormal coordination and muscle weakness. The results from
these motor studies are consistent with the observation that

SC mitochondrial dysfunction does not compromise SC
survival
To determine whether the axonal loss and demyelination observed in Tfam-SCKO animals was simply the result of SC death,
we assessed changes in SC numbers in the nerves of these animals.
Remarkably, we found no differences in the number of SC nuclei
between Tfam-SCKO sciatic nerve and littermate controls up to 8
months of age (Fig. 7a,b). Moreover, by crossing Tfam-SCKO
mice to Cre-inducible Rosa26-YFP reporter animals, we were
able to confirm that, at all ages examined, Tfam-deficient SCs
present in Tfam-SCKO nerves (identified by their excisiondependent YFP fluorescence) remained viable (Fig. 7a,c). These
results indicate that the survival of Tfam-deficient SCs was not
compromised despite severe mtDNA depletion and respiratory
chain abnormalities.
Consistent with the viability of Tfam-SCKO SCs, we did not
detect any differences in TUNEL staining, a marker of cell death,
between Tfam-SCKO sciatic nerve and controls at different ages
(Fig. 7a,d). Similarly, staining with an antibody that recognizes
the proliferation marker phosphohistone 3 showed no changes in
proliferation that could compensate for the potential loss of
Tfam-deficient SCs in Tfam-SCKO nerves (data not shown). The
pathology observed in Tfam-SCKOs, therefore, was not due to
the loss of SCs. Together, our findings indicate that normal mitochondrial function is not required for SC survival, but is essential for maintenance of axonal survival and normal peripheral
nerve function.
Tfam-deficient SCs support axonal regeneration but fail to
remyelinate following injury
Schwann cells play a critical role in promoting axonal regeneration following peripheral nerve injury. Upon degeneration of peripheral axons, SCs in the distal stump undergo an orchestrated
process that helps support axonal regeneration (Geuna et al.,
2009). To determine whether disrupting mitochondrial function
affects the ability of SCs to support axonal regeneration, we studied the response of these cells after peripheral nerve crush injury
in 2-month-old ctrl and Tfam-SCKO mice. At this age, the peripheral nerves of Tfam-SCKOs show modest pathology that is
mainly limited to unmyelinated fibers yet mitochondrial function has already been severely disrupted (see above).
We first looked at the initial response of SCs to axonal degeneration by assessing changes in SC proliferation and in their ability to break down existing myelin. Within the first few days after
losing contact with axons, SCs dedifferentiate and start to proliferate (Geuna et al., 2009). Immunostaining of nerves harvested
4 d after injury distal to the site of crush using a phosphohistone
3 antibody showed no impairment in the ability of Tfamdeficient SCs to proliferate following axonal loss (Fig. 8a,b).
Nerve regeneration also depends on the ability of SCs to break
down existing myelin and remove the resulting debris. This process starts immediately after injury and takes place over a period
of 3– 6 weeks (Geuna et al., 2009). We did not observe differences
in the amount of myelin debris present in ctrl and Tfam-SCKO
nerves 3 weeks after injury, suggesting that disruption of mitochondrial function in SCs does not interfere with their ability to
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ity of Tfam-deficient SCs to myelinate is
likely a direct consequence of their disrupted mitochondrial metabolism.
Regenerated Remak bundles were also
absent in Tfam-SCKO nerves compared
with ctrl littermates 3 weeks after crush
injury. Instead, we observed pathological
bundles of unorganized unmyelinated
axons interspersed by bands of Bungner
(Fig. 8g5,g6 ), similar to those present in
2-month-old Tfam-SCKO mice before
injury. We conclude that disrupting SC
mitochondrial function does not affect
the ability of these glia to dedifferentiate,
proliferate, or support axonal regeneration following injury. Normal SC mitochondrial metabolism, however, is
essential for SCs to form mature myelin
and Remak bundles, suggesting that the
formation and maintenance of these mature structures poses a high metabolic
challenge.

Discussion
In the present study, we describe the generation and characterization of mice with
disrupted mitochondrial function only in
SCs. We found that the induction of SCspecific mitochondrial dysfunction did
not affect the survival of these cells but
resulted in a severe, progressive peripheral
neuropathy characterized by extensive axonal degeneration. SC mitochondrial dysfunction, therefore, disrupts the axoglial
Figure 7. SC mitochondrial dysfunction does not compromise SC survival. a, b, Nuclear staining (a, DAPI) and quantification (b) interactions required for the long-term
shows that there is no difference in the number of SC nuclei between Tfam-SCKO and ctrl sciatic nerves at different ages. a, c, support of axons and is a likely contribuQuantification of Rosa-YFP immunofluorescence (a, YFP/DAPI; c) in Tfam-SCKO/Rosa-YFP nerves at different ages shows that the tor to the clinical impairment of patients
majority of SCs are Tfam-deficient at all ages. a, d, Quantification of TUNEL immunohistochemistry (a, TUNEL/DAPI; d) of Tfam- suffering from peripheral neuropathies.
SCKO and ctrl littermate shows no differences in the number of TUNEL-positive cells at different ages, indicating that SCs are able
Mitochondrial dysfunction is a comto survive despite the disruption in their mitochondria. Scale bar, 100 m. Error bars indicate SEM. n ⫽ 3 mice per genotype at
mon cause of peripheral neuropathies. An
each age.
extensive body of literature has now addressed how neuronal/axonal mitochondria may contribute to the pathology
break down and remove myelin following axonal degeneration
observed in these diseases (Niemann et al., 2006; Baloh, 2008).
(Fig. 8c).
The results described above show for the first time that disrupted
We next studied the ability of Tfam-deficient SCs to support
mitochondrial function specifically in SCs can itself also cause
axonal regeneration by analyzing toluidine blue-stained plastic
axonal degeneration and peripheral nerve disease. These findings
sections of Tfam-SCKO and ctrl nerves collected distal to the site
are consistent with observations in patients suffering from polyof crush 3 weeks after injury. At this time, we found that substanneuropathies associated with diabetes, HIV/AIDS, and mitotial axonal regeneration and SC remyelination had already taken
chondrial disorders, in which most nerve mitochondrial
place in ctrl nerves (Fig. 8d). In Tfam-SCKO nerves, however, we
abnormalities are localized to SCs (Schroder, 1993; Kalichman
observed a striking decrease in the number of myelinated fibers
et al., 1998).
(Fig. 8d). Interestingly, examination of Tfam-SKO nerves by elecMoreover, the Tfam-SCKO mice generated in our study recatron microscopy revealed that this decrease in myelinated profiles
pitulated a number of critical pathological features of human
was not due to the inability of Tfam-deficient SCs to support
peripheral neuropathies. Disrupting mitochondrial metabolism
axonal regrowth. In fact, the total number of fibers (myelinated
specifically in SCs was sufficient to induce both axonal degenerand unmyelinated) distal to the crush site was equivalent between
ation as well as demyelination. Tfam-SCKOs also displayed distal
ctrl and Tfam-SCKO nerves 3 weeks after injury (Fig. 8e,f ).
weakness and sensory deficits, two common problems in human
Moreover, the majority of regenerated axons in Tfam-SCKO
patients. Finally, Tfam-SCKOs suffered preferential early loss of
nerves 3 weeks after injury were associated with SCs in the typical
unmyelinated C-fibers followed by the degeneration of large1:1 ratio (Fig. 8g1– g4 ). Tfam-deficient SCs, however, failed to
caliber myelinated axons. This was of particular interest because
form mature myelin. Given that the proportion of axons of large
preferential loss of small-caliber unmyelinated fibers is characenough caliber to induce myelination (⬎1 m in diameter) was
not different between ctrl and Tfam-SCKOs (Fig. 8h), the inabilteristic of peripheral and optic neuropathies associated with
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systemic diseases such as diabetes or with
exposure to environmental toxins (Kennedy et al., 1996; Sadun, 2002; McArthur
et al., 2005). Together, our results indicate
that SC mitochondria are underappreciated contributors to the abnormalities observed in peripheral neuropathies.
Furthermore, key pathological features
commonly encountered in human peripheral nerve disease can potentially be
explained by SC-specific mitochondrial
dysfunction.
The findings described in the present
paper are consistent with a growing body
of literature that implicates glial dysfunction in a number of neurodegenerative
diseases traditionally thought to be cell
autonomous. This is best exemplified by
amyotrophic lateral sclerosis (ALS), a disease characterized by premature death of
motor neurons that is sometimes linked
to dominant mutations in the antioxidant
protein superoxide dismutase 1 (SOD1)
(Rosen et al., 1993). While neuronal expression of mutant SOD1 in transgenic
mouse models of ALS was found to be important for the initial timing of disease
onset (Boillee et al., 2006; Yamanaka et al.,
2008; Wang et al., 2009), expression in
microglia cells (Boillee et al., 2006; Wang
et al., 2009) and astrocytes (Yamanaka et
4

Figure 8. Tfam-deficient SCs support axonal regeneration but fail to remyelinate following injury. a, b, Phosphohistone 3 (PH3)
immunostaining (a) and quantification (b) show that there is no difference in the number of proliferating SCs (arrowheads)

between Tfam-SCKO and ctrl sciatic nerves 4 d after crush injury. Scale bar, 100 m. Error bars indicate SEM. n ⫽ at least 3
mice per genotype. c, Quantification of the amount of myelin
debris present in ctrl and Tfam-SCKO nerves 3 weeks after
crush injury shows no impairment in the ability of Tfamdeficient SCs to break down existing myelin. Error bars indicate
SEM. n ⫽ 3 mice per genotype. d, Quantification of the number of myelinated profiles in ctrl and Tfam-SCKO nerves 3
weeks after crush distal to the site of injury shows a significant
decrease (p ⬍ 0.001, two-tailed Student’s t test) in the number of myelinated profiles formed by Tfam-deficient SCs following injury. Error bars indicate SEM. n ⫽ 3 mice per
genotype. e, Electron micrographs of ctrl and Tfam-SCKO
nerves 3 weeks after crush depicting the inability of Tfamdeficient SCs to form mature myelin even though they are capable of supporting axonal regeneration. Scale bar, 2 m. f,
Quantification of the total number of fibers (myelinated and
unmyelinated) distal to the site of injury 3 weeks after crush
shows no differences between Tfam-SCKO and ctrl nerves,
confirming that Tfam-deficient SCs are able to support axonal
regeneration. Error bars indicate SEM. n ⫽ 3 mice per genotype. g, Electron micrographs of ctrl (g1) and Tfam-SCKO (g2–
g4) large-caliber fibers distal to the site of injury 3 weeks after
crush showing that, while Tfam-deficient SCs are capable of
ensheathing axons and forming one-to-one associations with
them (arrowheads, axons; arrows, SCs), they are not able to
form mature myelin. Regenerating Remak bundles are present
in ctrl nerves (g5) but are absent in Tfam-SCKO nerves (g6;
arrowheads, axons; arrows, SCs). h, Proportion of axons ⬎1
m is similar between Tfam-SCKO and ctrl nerves following
injury and cannot explain the absence of myelin in Tfam-SCKO
nerves.
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al., 2008) was found to significantly contribute to disease progression. Similarly, in a mouse model of Parkinson’s disease,
oligodendrocyte-specific overexpression of the disease-related
protein ␣-synuclein resulted in neurodegeneration (Yazawa et
al., 2005). A central role for glia in diseases such as Huntington’s,
spinocerebellar ataxia, or Alzheimer’s has also been reported (for
review, see Ilieva et al., 2009). The development of effective therapies for peripheral neuropathies and neurodegenerative disorders, therefore, will need to address the contribution of SCs and
other glia to disease progression.
An unexpected finding of our work was that severe mtDNA
depletion and respiratory chain abnormalities in the SCs of
Tfam-SCKO mice did not affect their survival. This observation
suggests that SCs have an adaptable energy metabolism and that
their survival and ATP production are not fully dependent on
mitochondrial function. Previous studies looking at the effect of
Tfam deletion in a number of tissues have indeed reported cellspecific metabolic changes that take place following the Tfam
deletion-induced disruption of the electron transport chain. For
example, following the muscle-specific deletion of Tfam, myocytes increased their mitochondrial mass to compensate for any
deficiencies in their respiratory chain (Wredenberg et al., 2002).
Cardiomyocytes, however, were reported to switch to a primarily
glycolytic metabolism in response to the heart-specific excision of
Tfam (Hansson et al., 2004). Some of these adaptations likely
account for the limited or largely delayed cell death observed in
several tissue-specific Tfam KOs (Larsson et al., 1998; Wang et al.,
1999; Silva et al., 2000; Sorensen et al., 2001; Wredenberg et al.,
2002). Specific metabolic adaptations following Tfam depletioninduced mitochondrial dysfunction may also explain why SC viability was not affected in Tfam-SCKO mice.
SCs have, in fact, been hypothesized to be largely glycolytic
and rely on the nonoxidative catabolism of glucose to meet their
energy needs (Pellerin and Magistretti, 2003). This idea is supported by the observation that, in explant systems, SCs take up a
disproportionately large amount of glucose (Vega et al., 2003).
The fact that disruption of mitochondrial energy metabolism in
Tfam-SCKO mice did not affect SC survival provides indirect
support for this hypothesis. Our current knowledge of the basic
energy metabolism and requirements of SCs, however, is still very
rudimentary. Future work aimed at understanding the metabolic
changes that take place in SCs following Tfam deletion-induced
respiratory chain deficiency should provide valuable insight into
both the biology and pathology of SCs.
Following peripheral nerve injury, SCs undergo a process of
dedifferentiation, proliferation, and formation of tubular structures known as bands of Bungner, which, together with their
production of neurotrophic factors, help support axonal regeneration (Geuna et al., 2009). Interestingly, we found that Tfam
depletion-induced mitochondrial dysfunction did not interfere
with the ability of SCs to perform these duties and support axonal
regrowth. However, Tfam-deficient SCs failed to redifferentiate
and form mature Remak bundles and myelin sheaths after having
promoted axonal regeneration. The high metabolic challenge
posed by the reconstruction of these mature structures, therefore,
appears to require an undisturbed SC mitochondrial anaplerotic
metabolism. Elucidation of deficiencies in the intermediate metabolism of Tfam-SCKOs could thus provide new targets whose
manipulation may promote the remyelination and the restoration of
normal nerve function in patients suffering from mitochondrialrelated peripheral neuropathies.
SCs have a primary role in supporting axonal function and
survival (Chen et al., 2003; Reddy et al., 2003; Meyer zu Horste et
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al., 2007), yet the mechanisms and cellular machinery underlying
SC preservation of axons still remain largely unknown. Others
have hypothesized that glial support requires axonal ensheathment as well as some myelin-related proteins. Trophic support of
axons through neurotrophic factors has also been postulated as a
potential mechanism behind glia-mediated axonal maintenance.
Metabolic support of axons by ensheathing cells is also a likely but
poorly understood mechanism of axonal preservation (Nave and
Trapp, 2008). For example, SCs may support axons through the
transfer of metabolites or by helping axons eliminate certain toxic
species, as is the case between CNS neurons and astrocytes (Benarroch, 2005). Our results show that SC mitochondria are essential for the SC-mediated support of axonal function and
survival. Given the central role of mitochondria in cellular energy
and anaplerotic metabolism, we speculate that the axonal degeneration in Tfam-SCKOs reflects a disruption of SC-mediated
metabolic support of axons. The preferential loss of small unmyelinated fibers early in the Tfam-SCKO disease process would
then reflect a greater dependence of these fibers on SC metabolic
support. Consistent with this hypothesis, unmyelinated axons
have been found to be more energetically demanding than myelinated axons and are estimated to consume 2.5- to 10-fold more
energy per action potential generated (Wang et al., 2008).
In summary, Tfam-SCKOs are, to our knowledge, the first
SC-specific metabolic mutant that recapitulates some of the pathology of human peripheral neuropathies. These mice demonstrate that SC-specific mitochondrial dysfunction can be
sufficient to cause both demyelination and axonal degeneration.
Our study also provides evidence that SC mitochondria help
maintain the axoglial interactions required for the long-term
support of axons. A greater understanding of SC mitochondria
and how to prevent their dysfunction is, therefore, relevant to the
treatment of patients suffering from peripheral neuropathies.

Notes
Supplementalmaterialforthisarticleisavailableathttp://www.genetics.wustl.
edu/jmlab/wp-content/uploads/2011/05/Viader-et-al_Schwann-cellmitochondrial-metabolism-supports-long-term-axonal-survival-andperipheral-nerve-function_Supplementary-Figure-1.pdf. Supplemental
Figure 1 shows that Tfam-SCKOs initially develop and myelinate normally.
This material has not been peer reviewed.
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